Medicamen Biotech Limited (MEDICAMEQ) — Tangible Net Worth Ratio
Medicamen Biotech Limited (MEDICAMEQ) has a Tangible Net Worth Ratio of 99.8% as of September 2025. This metric is calculated by deducting intangible assets (Rs6.59 Million) from net assets (Rs2.75 Billion) and expressing it as a percentage of total net assets. A higher ratio means that more of the company's equity is backed by tangible, balance-sheet-verifiable assets rather than goodwill, patents, or brand value. See Medicamen Biotech Limited shareholders equity for net asset value and shareholders' equity analysis.
Tangible NW Ratio
Net Assets (Equity)
Intangible Assets
Total Assets
Medicamen Biotech Limited Tangible Net Worth Ratio (2006–2025)
This chart shows how Medicamen Biotech Limited's Tangible Net Worth Ratio has changed across 20 annual periods from 2006 to 2025. As of September 2025, the ratio stands at 99.8%, reflecting net assets of Rs2.75 Billion with intangible assets of Rs6.59 Million INR. Also explore Medicamen Biotech Limited equity growth rate to track the company's year-over-year net asset growth rate.
Annual Tangible Net Worth Ratio for Medicamen Biotech Limited (2006–2025)
The table below presents the year-by-year Tangible Net Worth Ratio for Medicamen Biotech Limited from 2006 to 2025, covering 20 annual filings. Each row shows net assets, intangible assets, total assets, the tangible net worth ratio, and the change in percentage points versus the prior year. For the full company profile including market capitalisation, see how much is Medicamen Biotech Limited worth.
| Year | Tangible NW Ratio | Net Assets (INR) | Intangible Assets | Total Assets | Change (pp) |
|---|---|---|---|---|---|
| 2025 | 99.7% | Rs2.13 Billion | Rs7.42 Million | Rs2.97 Billion | ▲ +0.1 pp |
| 2024 | 99.6% | Rs2.07 Billion | Rs8.98 Million | Rs2.95 Billion | ▲ +0.0 pp |
| 2023 | 99.5% | Rs1.93 Billion | Rs8.98 Million | Rs2.79 Billion | ▼ -0.2 pp |
| 2022 | 99.8% | Rs1.46 Billion | Rs3.60 Million | Rs2.26 Billion | ▼ -0.1 pp |
| 2021 | 99.8% | Rs1.33 Billion | Rs2.04 Million | Rs1.94 Billion | ▲ +0.1 pp |
| 2020 | 99.8% | Rs1.21 Billion | Rs2.69 Million | Rs1.81 Billion | ▲ +0.2 pp |
| 2019 | 99.6% | Rs866.34 Million | Rs3.34 Million | Rs1.37 Billion | ▲ +0.0 pp |
| 2018 | 99.6% | Rs746.08 Million | Rs3.17 Million | Rs1.18 Billion | ▼ -0.3 pp |
| 2017 | 99.9% | Rs267.81 Million | Rs217.88K | Rs734.01 Million | ▲ +0.1 pp |
| 2016 | 99.8% | Rs179.09 Million | Rs307.44K | Rs600.18 Million | ▲ +0.1 pp |
| 2015 | 99.8% | Rs171.85 Million | Rs397.00K | Rs686.63 Million | ▲ +0.2 pp |
| 2014 | 99.5% | Rs165.38 Million | Rs761.57K | Rs645.79 Million | ▲ +0.3 pp |
| 2013 | 99.3% | Rs157.17 Million | Rs1.18 Million | Rs652.34 Million | ▲ +0.0 pp |
| 2012 | 99.2% | Rs201.01 Million | Rs1.53 Million | Rs689.07 Million | ▼ -0.8 pp |
| 2011 | 100.0% | Rs204.12 Million | Rs0.00 | Rs700.18 Million | ▲ +0.0 pp |
| 2010 | 100.0% | Rs162.61 Million | Rs0.00 | Rs576.83 Million | ▲ +0.0 pp |
| 2009 | 100.0% | Rs129.60 Million | Rs0.00 | Rs458.11 Million | ▲ +0.0 pp |
| 2008 | 100.0% | Rs115.83 Million | Rs0.00 | Rs517.72 Million | ▲ +0.0 pp |
| 2007 | 100.0% | Rs100.73 Million | Rs0.00 | Rs464.17 Million | ▲ +0.0 pp |
| 2006 | 100.0% | Rs85.67 Million | Rs0.00 | Rs338.18 Million | — |